Introduction to Bayesian methods I: measuring the strength of evidence

被引:108
作者
Goodman, SN [1 ]
机构
[1] Johns Hopkins Sch Med, Div Biostat, Dept Oncol, Baltimore, MD 21205 USA
关键词
D O I
10.1191/1740774505cn098oa
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Bayesian inference is a formal method to combine evidence external to a study, represented by a prior probability curve, with the evidence generated by the study, represented by a likelihood function. Because Bayes theorem provides a proper way to measure and to combine study evidence, Bayesian methods can be viewed as a calculus of evidence, not just belief. In this introduction, we explore the properties and consequences of using the Bayesian measure of evidence, the Bayes factor (in its simplest form, the likelihood ratio). The Bayes factor compares the relative support given to two hypotheses by the data, in contrast to the P-value, which is calculated with reference only to the null hypothesis. This comparative property of the Bayes factor, combined with the need to explicitly predefine the alternative hypothesis, produces a different assessment of the strength of evidence against the null hypothesis than does the P-value, and it gives Bayesian procedures attractive frequency properties. However, the most important contribution of Bayesian methods is the way in which they affect both who participates in a scientific dialogue, and what is discussed. With the emphasis moved from "error rates" to evidence, content experts have an opportunity for their input to be meaningfully incorporated, making it easier for regulatory decisions to be made correctly.
引用
收藏
页码:282 / 290
页数:9
相关论文
共 15 条
[1]  
BERGER JO, 1988, IMS SERIES, P6
[2]   Likelihood methods for measuring statistical evidence [J].
Blume, JD .
STATISTICS IN MEDICINE, 2002, 21 (17) :2563-2599
[3]   PLACING TRIALS IN CONTEXT USING BAYESIAN-ANALYSIS - GUSTO REVISITED BY REVEREND BAYES [J].
BROPHY, JM ;
JOSEPH, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (11) :871-875
[4]   BAYESIAN STATISTICAL-INFERENCE FOR PSYCHOLOGICAL-RESEARCH [J].
EDWARDS, W ;
LINDMAN, H ;
SAVAGE, LJ .
PSYCHOLOGICAL REVIEW, 1963, 70 (03) :193-242
[5]   Carvedilol and the Food and Drug Administration approval process:: An introduction [J].
Fisher, LD ;
Moyé, LA .
CONTROLLED CLINICAL TRIALS, 1999, 20 (01) :1-15
[6]   Carvedilol and the food and drug administration (FDA) approval process: The FDA paradigm and reflections on hypothesis testing [J].
Fisher, LD .
CONTROLLED CLINICAL TRIALS, 1999, 20 (01) :16-39
[7]  
Gigerenzer G., 1989, EMPIRE CHANCE
[8]   Toward evidence-based medical statistics.: 1:: The P value fallacy [J].
Goodman, SN .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (12) :995-1004
[9]  
JOSEPH B, 1999, RETHINKING FDN STAT
[10]  
Lilford RJ, 1996, BRIT MED J, V313, P603